Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
Current Opinion in Virology|February 1, 2016
Immune-surveillance through exhausted effector T-cellsDietmar Zehn, Daniel T Utzschneider, Robert ThimmeNature Reviews. Immunology|October 9, 2019
Precursor exhausted T cells: key to successful immunotherapy?Axel Kallies, Dietmar Zehn, Daniel T UtzschneiderNature|February 3, 2009
Complete but curtailed T-cell response to very low-affinity antigenDietmar Zehn, Sarah Y Lee, Michael J BevanJournal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Cutting edge: TCR revision affects predominantly Foxp3 cells and skews them toward the Th17 lineageDietmar Zehn, Michael J Bevan, Pamela J FinkJournal of Autoimmunity|July 6, 2014
PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in miceFlorian Wiede, Alexandra Ziegler, Dietmar Zehn, et al.Immunity|August 18, 2016
T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral InfectionsDaniel T Utzschneider, Mélanie Charmoy, Vijaykumar Chennupati, et al.Cellular and Molecular Life Sciences : CMLS|April 25, 2012
TCR signaling requirements for activating T cells and for generating memoryDietmar Zehn, Carolyn King, Michael J Bevan, et al.International Immunology|October 13, 2006
Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-primingDietmar Zehn, Cyril J Cohen, Yoram Reiter, et al.European Journal of Immunology|May 27, 2004
Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cellsDietmar Zehn, Cyril J Cohen, Yoram Reiter, et al.Nature Immunology|July 18, 2024
T cell dysfunction and therapeutic intervention in cancerCaitlin C Zebley, Dietmar Zehn, Stephen Gottschalk, et al.Pageof 10